| Article

A new genetic test has the potential to aid clinicians in identifying patients at risk of addiction to opioids, according to the results of research led by Sherman Chang, PhD, vice president of research and development at AutoGenomics, Inc., Carlsbad, California. The team identified 16 genetic...

| Article

It is possible to provide the best care for a patient and protect yourself from criminal and civil liability. In fact, when you do one right, you do the other right as well. Typically you want to look for three things as a prescriber of any controlled prescription medication, opioid or otherwise...

| Article

Senior PAINWeek faculty member Douglas Gourlay, MD, MSc, FRCPS, FASAM, has spoken often of the need for frontline practitioners with an interest in pain to become “talented amateurs” in addiction medicine. A new consensus document released by the American Society of Addiction Medicine (ASAM) may...

| Video

At PAINWeek 2016, a panel of medical, legal, and pharmacy specialists convened to offer their views on the recently introduced prescribing guidelines for chronic pain from the CDC. In this segment, Dr. Ziegler and Dr. Fudin summarize some of the concerns voiced over the guideline development process...

| Article

Much of the publicity today, as well as initiatives like the CDC guidelines, really focus on the outpatient problems with chronic pain patients. But there’s a growing concern with how we prescribe opioids for post-op pain control. There is a fair amount of literature that’s emerging about whether...

| Video

A clinical pharmacy specialist turns the spotlight on an option for chronic pain management that many clinicians may not have considered.  Buprenorphine offers advantages to patients who are indicated for opioid therapy, but are at risk for adverse effects,  While reimbursement is an issue, it...

| Video

One approach to maintaining the balance between risks and benefits of opioid therapy for chronic pain has been the development of abuse deterrent formulations. A pain management PA provides an overview of abuse deterrent technologies, both existing and emerging. While developments are encouraging...

| Article

Results of a recent review of 7 studies concludes that rotator cuff disease, a disorder that impacts up to one-half of people over age 50, may be linked to genetics. The condition is associated with loss of function and shoulder pain, and is usually connected to injury or sustained overuse. A...

| Podcast

Managing risk is an essential part of medical practice, particularly in light of the reported increase in morbidity and mortality associated with the use of opioids. Recent anecdotal data indicate that as a result of the "opioid crisis," patients are being told by their prescribers that they can no...

| Podcast

There are over 16,000 deaths per year associated with opioid induced respiratory depression and overdose. These occur in the substance abuse population and also in chronic pain patients who are legitimately receiving opioids. This interactive lecture will review unexpected and unanticipated risks of...

Subscribe to risk assessment

Sign-Up